Business Description
Mind Medicine Inc
NAICS : 325199
SIC : 3741
Share Class Description:
NEOE:MMED: Ordinary SharesCompare
Compare
Traded in other countries / regions
MNMD.USAMMED.CanadaMMQ.Germany IPO Date
2020-03-03Description
Mind Medicine Inc is a psychedelic medicine biotech company that discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of treatments based on psychedelic substances including Psilocybin, LSD, MDMA, DMT, and an Ibogaine derivative, 18-MC. The firm is having an approach towards developing the next generation of psychedelic inspired medicines and therapies.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1553.07 | |||||
| Equity-to-Asset | 0.75 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 5.68 | |||||
| 9-Day RSI | 17.1 | |||||
| 14-Day RSI | 26.35 | |||||
| 6-1 Month Momentum % | 28.24 | |||||
| 12-1 Month Momentum % | 15.42 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.41 | |||||
| Quick Ratio | 3.41 | |||||
| Cash Ratio | 3.33 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -3.7 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -57.01 | |||||
| ROA % | -48.44 | |||||
| ROIC % | -212.25 | |||||
| ROCE % | -60.68 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 1.15 | |||||
| Price-to-Tangible-Book | 1.45 | |||||
| EV-to-EBIT | -0.06 | |||||
| EV-to-EBITDA | -0.06 | |||||
| EV-to-Forward-EBITDA | -0.05 | |||||
| EV-to-FCF | -0.18 | |||||
| Price-to-Net-Current-Asset-Value | 1.46 | |||||
| Price-to-Net-Cash | 1.51 | |||||
| Earnings Yield (Greenblatt) % | -1549.2 |
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Mind Medicine Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil C$) | |||
| EPS (TTM) (C$) | -2.673 | ||
| Beta | 3.54 | ||
| Volatility % | 80.96 | ||
| 14-Day RSI | 26.35 | ||
| 14-Day ATR (C$) | 0.350731 | ||
| 20-Day SMA (C$) | 5.189 | ||
| 12-1 Month Momentum % | 15.42 | ||
| 52-Week Range (C$) | 2.88 - 6.8 | ||
| Shares Outstanding (Mil) | 39.72 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Mind Medicine Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Mind Medicine Inc Stock Events
| Event | Date | Price(C$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Mind Medicine Inc Frequently Asked Questions
What is Mind Medicine Inc(NEOE:MMED)'s stock price today?
The current price of NEOE:MMED is C$4.17. The 52 week high of NEOE:MMED is C$6.80 and 52 week low is C$2.88.
When is next earnings date of Mind Medicine Inc(NEOE:MMED)?
The next earnings date of Mind Medicine Inc(NEOE:MMED) is 2023-11-10 Est..
Does Mind Medicine Inc(NEOE:MMED) pay dividends? If so, how much?
Mind Medicine Inc(NEOE:MMED) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers